Contraception utilization in women with pregestational diabetes. Eur J Contracept Reprod Health Care 2022 Aug;27(4):317-321
Date
08/11/2022Pubmed ID
35946609Pubmed Central ID
PMC9759819DOI
10.1080/13625187.2022.2074392Scopus ID
2-s2.0-85131512177 (requires institutional sign-in at Scopus site) 2 CitationsAbstract
OBJECTIVE: To compare contraception use between women with and without pregestational diabetes.
METHODS: Cross-sectional data on women aged 18-44 years from 2011 to 2017 National Survey of Family Growth (NSFG) was analysed. Maternal diabetes was defined as the presence of pre-gestational type 1 or type 2 diabetes. Bivariate and multiple logistic regression analyses were run to evaluate the association between the use of contraception and by contraception type: permanent, long-acting reversible contraception (LARC), other hormonal method, other non-hormonal method, and none, and maternal diabetes status, controlling for relevant covariates.
RESULTS: Among the total study sample of 28,454, 1344 (4.7%) had pregestational diabetes. Unadjusted analysis showed women with a history of pregestational diabetes were more likely to use permanent contraception following pregnancy (58.0% vs. 38.7%, p < 0.001) or no contraception (27.2% vs. 24.5%, p < 0.001), but less likely to use LARC (3.4% vs. 11.7%, p < 0.001), other hormonal contraception (4.1% vs. 8.9%, p < 0.001), or other non-hormonal contraception (7.2% vs. 16.4%, p < 0.001). In adjusted analyses, permanent (aOR 1.62, 95% CI 0.72-2.26) remained significant, however the differences were no longer statistically significant: LARC (aOR 0.34, 95% CI 0.12-1.00); other hormonal (aOR 0.61, 95% CI 0.27-1.35); other non-hormonal (aOR 0.59, 95% CI 0.25-1.43); and None (aOR 1.11, 95% CI 0.65-1.89).
CONCLUSION: In this analysis, we found that women with pregestational diabetes were more likely to use permanent contraception methods compared to women without pregestational diabetes; however over a quarter of women with pregestational diabetes did not use contraception between pregnancies.
Author List
Walker SL, Anguzu R, Egede LE, Palatnik AAuthors
Ronald Anguzu MD, PhD Assistant Professor in the Institute for Health and Humanity department at Medical College of WisconsinAnna Palatnik MD Associate Professor in the Obstetrics and Gynecology department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
ContraceptionContraception Behavior
Cross-Sectional Studies
Diabetes Mellitus, Type 2
Female
Humans
Long-Acting Reversible Contraception
Pregnancy
